| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | WE92U03C5Z |
| InChI Key | HEKAIDKUDLCBRU-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H21N3OS |
| Molecular Weight | 399.52 |
| AlogP | 6.0 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 54.88 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | MAP kinase p38 alpha inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | - | - | - | 4 | |
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase MAPK family
CMGC protein kinase p38 subfamily
|
- | 7-240 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 91360 |
| ChEMBL | CHEMBL363648 |
| DrugBank | DB16108 |
| EPA CompTox | DTXSID20184412 |
| FDA SRS | WE92U03C5Z |
| Guide to Pharmacology | 9328 |
| PDB | T75 |
| PubChem | 9952773 |
| SureChEMBL | SCHEMBL297487 |
| ZINC | ZINC000006717791 |